Issue Date: October 29, 2012
Calysta Is New Player In Industrial Biotech
A new company, Calysta Energy, has been created to produce industrial chemicals and liquid fuels from natural gas. Based in Menlo Park, Calif., Calysta is a spin-off of the synthetic biology company DNA2.0. Calysta will use a biological technology to convert methane into fuels and chemicals. Alan Shaw, former CEO of the biocatalysis firm Codexis, will lead Calysta; biotech industry executive Josh Silverman is the new firm’s chief scientific officer.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society